Influence of demographic, lymphoma-specific, and HIV-specific factors on outcome
. | Overall survival . | . | . | ||
|---|---|---|---|---|---|
| Prognostic factors . | No. . | Univariate HR*(95% CI) . | Multivariate HR†(95% CI) . | ||
| Risk factor for HIV infection | |||||
| Intravenous drug use | 47‡ | 1§ | 1§ | ||
| Male homosexuality | 22 | 2.41 (1.11-5.23)∥ | 2.34 (1.07-5.08)∥ | ||
| Histology | |||||
| DLBCL | 52‡ | 1§ | 1§ | ||
| Burkitt lymphoma | 21 | 2.60 (1.20-5.64)¶ | 2.24 (1.01-4.97)# | ||
| HIV viral load at the end of R-CDE | |||||
| Undetectable | 36‡ | 1§ | 1§ | ||
| Detectable | 26 | 2.39 (1.10-5.18)∥ | 1.96 (0.88-4.36)** | ||
. | Overall survival . | . | . | ||
|---|---|---|---|---|---|
| Prognostic factors . | No. . | Univariate HR*(95% CI) . | Multivariate HR†(95% CI) . | ||
| Risk factor for HIV infection | |||||
| Intravenous drug use | 47‡ | 1§ | 1§ | ||
| Male homosexuality | 22 | 2.41 (1.11-5.23)∥ | 2.34 (1.07-5.08)∥ | ||
| Histology | |||||
| DLBCL | 52‡ | 1§ | 1§ | ||
| Burkitt lymphoma | 21 | 2.60 (1.20-5.64)¶ | 2.24 (1.01-4.97)# | ||
| HIV viral load at the end of R-CDE | |||||
| Undetectable | 36‡ | 1§ | 1§ | ||
| Detectable | 26 | 2.39 (1.10-5.18)∥ | 1.96 (0.88-4.36)** | ||